BioSpace News Archive

Immutep Limited announces that the requisite number of predefined patient responses has been exceeded in cohort 1 of Part A) of the TACTI-002 Phase II clinical trial based on an interim analysis.

Special Projects Laboratory opened in EKF’s Cardiff HQ to develop new applications in non-core markets and support other global diagnostics R&D facilities

SCORR Marketing is excited to announce that Krystle Buntemeyer, president of SCORR Marketing, is the recipient of the 2019 Distinguished Young Alumni Award from the University of Nebraska at Kearney Alumni Association.

GENFIT announced Dr. Dean Hum’s appointment as President of GENFIT Corp. and Dr. Suneil Hosmane as Head of Global Diagnostics.

International precision medicine firm Lucence Diagnostics announced that it has received the Clinical Laboratory Improvement Amendments certification for its laboratory in Singapore from the U.S. Department of Health and Human Services’ Centers for Medicare & Medicaid Services.

Phase 1/2, open-label, multicenter study ongoing to evaluate KY1044 as a single agent and in combination with anti-PD-L1 (atezolizumab) in adult patients with advanced malignancies Cambr

Eosera gives a sneak peek into new products and announces the move to a bigger location due to rapid growth.

Eisai Co., Ltd. and FRONTEO, Inc. announced that they have launched the tumbling and falling prediction system Coroban to medical institutions in Japan on September 26, 2019.

SphingoTec GmbH announced that novel data on its sphingotest penKid assay for Proenkephalin, a unique and proprietary biomarker for real-time assessment of kidney function, will be presented at the 32nd Annual Congress of the European Society of Intensive Care Medicine taking place in Berlin on September 28 to October 2, 2019.

MyoKardia, Inc., announced that Taylor Harris, Chief Financial Officer, will participate in a fireside chat at the 2019 Cantor Global Healthcare Conference on Thursday, October 3, 2019, at 4:10 p.m. ET in New York, NY.